Department of Health and Human Services

Patient Network

Bringing Your Voice to Drug and Device Approval and Safety

To view our March 31, 2014 LiveChat.


Information on diabetes-related treatments.


Advisory committees provide FDA with independent opinions and recommendations from outside experts.

Opportunities for Input

FDA and Diabetes

An estimated 29.1 million (21.0 million diagnosed and 8.1 million undiagnosed) people in the U.S.—approximately 9.3% of the population—have diabetes.  An estimated 86 million people in the U.S. (1 out of 3 adults) have prediabetes and 9 out of 10 people in the U.S. do not know they have prediabetes.

With the incidence of diabetes skyrocketing, it is important to FDA that we do what we can to inform patients and the health professionals. On the Patient Network Diabetes site, there is diabetes-related information tailored to patients with Type 1 and Type 2 diabetes, with links to FDA web pages and other trusted government web sites. FDA is committed to getting accurate, science-based information in the hands of people with diabetes and the people who provide medical care - so they can recommend and use foods, medicines, and devices to maintain and improve patient health.

What's new in Diabetes?


Subscribe to FDA Updates

  • FDA Diabetes Monitor - FDA's Diabetes e-mail list delivers updates on safety and regulatory issues related to diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
  • MedWatch E-list - Clinically important medical product safety alerts, delivered via e-mail and/or SMS text messages.